Zevra Therapeutics Stock Quote ZVRA - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

9.125

Bid

9.11

Ask

9.45

Volume

0.00 Day's Range 0.00

4.20 52 Week Range 9.76

Market Cap

498.952M

Previous Close

9.125

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

546,367

Shares Outstanding

54,679,641

Dividend Yield

PE Ratio

-4.73

Earnings Per Share (EPS)

-1.93

Revenue

23.61M

Net Profit

-105.51M

Zevra Therapeutics, Inc. is a rare disease therapeutics company. The Company is engaged in creating therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical-stage pipeline and ... Zevra Therapeutics, Inc. is a rare disease therapeutics company. The Company is engaged in creating therapies for diseases with limited or no treatment options. The Company has a diverse portfolio of products and product candidates, which includes a combination of both a clinical-stage pipeline and commercial stage assets. It employs its LAT platform technology to create a portfolio of approved products. Its product candidates include Arimoclomol, KP1077IH, KP1077N and AZSTARYS. Arimoclomol is an orally delivered, investigational product candidate being developed for Niemann-Pick disease type C (NPC). KP1077 is the Company's lead clinical development product candidate, which is being developed as a treatment for idiopathic hypersomnia (IH) and narcolepsy. KP1077 is comprised solely of serdexmethylphenidate (SDX), the Company's prodrug of d-methylphenidate (d-MPH). AZSTARYS is a prodrug for the treatment of ADHD in patients aged six years or older. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.kempharm.com

Headquarters

Wilmington, Delaware, USA

Founded

Zevra Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ZVRA. The last closing price for Zevra Therapeutics was $9.13. Over the last year, Zevra Therapeutics shares have traded in a share price range of $ 4.20 to $ 9.76.

Zevra Therapeutics currently has 54,679,641 shares outstanding. The market capitalization of Zevra Therapeutics is $498.95 million. Zevra Therapeutics has a price to earnings ratio (PE ratio) of -4.73.

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.125	-1.35135135135	9.25	9.62	8.99	575861	9.25989679	CS
4	0.215	2.41301907969	8.91	9.62	8.21	573761	8.92462203	CS
12	0.965	11.8259803922	8.16	9.62	6.19	546367	8.0448946	CS
26	0.725	8.63095238095	8.4	9.62	6.19	502034	8.05874013	CS
52	4.475	96.2365591398	4.65	9.76	4.2	659634	7.71684164	CS
156	3.475	61.5044247788	5.65	9.76	3.89	416621	6.95902549	CS
260	3.475	61.5044247788	5.65	9.76	3.89	416621	6.95902549	CS

ZVRA - Frequently Asked Questions (FAQ)

What is the current Zevra Therapeutics share price?

The current share price of Zevra Therapeutics is $ 9.125

How many Zevra Therapeutics shares are in issue?

Zevra Therapeutics has 54,679,641 shares in issue

What is the market cap of Zevra Therapeutics?

The market capitalisation of Zevra Therapeutics is USD 498.95M

What is the 1 year trading range for Zevra Therapeutics share price?

Zevra Therapeutics has traded in the range of $ 4.20 to $ 9.76 during the past year

What is the PE ratio of Zevra Therapeutics?

The price to earnings ratio of Zevra Therapeutics is -4.73

What is the cash to sales ratio of Zevra Therapeutics?

The cash to sales ratio of Zevra Therapeutics is 21.12

What is the reporting currency for Zevra Therapeutics?

Zevra Therapeutics reports financial results in USD

What is the latest annual turnover for Zevra Therapeutics?

The latest annual turnover of Zevra Therapeutics is USD 23.61M

What is the latest annual profit for Zevra Therapeutics?

The latest annual profit of Zevra Therapeutics is USD -105.51M

What is the registered address of Zevra Therapeutics?

The registered address for Zevra Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Zevra Therapeutics website address?

The website address for Zevra Therapeutics is www.kempharm.com

Which industry sector does Zevra Therapeutics operate in?

Zevra Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ACXPAcurx Pharmaceuticals Inc	$ 0.8157 (165.61%)	27.99M
SLRXSalarius Pharmaceuticals Inc	$ 1.28 (104.77%)	21.45M
CEROCERo Therapeutics Holdings Inc	$ 13.36 (94.53%)	3.09M
VERVVerve Therapeutics Inc	$ 11.03 (75.92%)	3.1M
SAFXXCF Global Inc	$ 3.72 (68.33%)	10.46M
RUNSunrun Inc	$ 6.51 (-32.47%)	900.47k
LDTCLeddarTech Holdings Inc	$ 0.15 (-27.33%)	585.28k
SEDGSolarEdge Technologies Inc	$ 17.85 (-25.56%)	345.28k
DYNDyne Therapeutics Inc	$ 10.50 (-24.02%)	26.72k
CDTGCDT Environmental Technology Investment Holdings Ltd	$ 1.05 (-23.44%)	95.19k
GTIGraphjet Technology	$ 0.0842 (9.92%)	71.28M
TDTHTrident Digital Tech Holdings Ltd	$ 0.2807 (14.81%)	32.3M
ACXPAcurx Pharmaceuticals Inc	$ 0.8157 (165.61%)	27.99M
GNLNGreenlane Holdings Inc	$ 0.0116 (-6.45%)	27.74M
SLRXSalarius Pharmaceuticals Inc	$ 1.28 (104.77%)	21.45M